Clinical Trials List
2015-07-31 - 2018-07-31
Phase II
Terminated4
ICD-10C50
Malignant neoplasm of breast
ICD-9174.0
Malignant neoplasm of female breast, nipple and areola
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- MING-YANG WANG Division of General Surgery
- 張端瑩 Division of Hematology & Oncology
- 郭文宏 Division of General Surgery
- SUNG-HSIN KUO Division of Hematology & Oncology
- 羅喬 Division of General Surgery
- YEN-SHEN LU Division of Hematology & Oncology
- 楊雅雯 Division of General Surgery
- 林璟宏 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Liang-Chih Liu Division of General Surgery
- Chih-Jung Chen Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ta-Chung Chao Division of Hematology & Oncology
- Yi-Fang Tsai Division of General Surgery
- 邱仁輝 Division of General Surgery
- Chun-Yu Liu Division of Hematology & Oncology
- 林永慧 Division of Radiology
- 金光亮 Division of General Surgery
The Actual Total Number of Participants Enrolled
1 Terminated
Audit
None
Co-Principal Investigator
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
250 participants
